Skip to main content
Premium Trial:

Request an Annual Quote

Commonwealth Biotech Wins $2.35M in Forensic, Biodefense Contracts

This article has been updated from a previous version. The original article incorrectly said that the award was from a Virginia state agency.
 
NEW YORK (GenomeWeb News) – Commonwealth Biotechnologies said today that it has recently received approximately $2.35 million in new contracts related to forensic DNA sequence analysis and proteomics for pathogen detection.
 
Specifically, an undisclosed state agency has awarded Commonwealth approximately $1.45 million over five years to fund Commonwealth’s reference lab, Fairfax Identity Labs, for DNA sequence analysis of convicted offender samples. The analysis results will be entered into the Federal Bureau of Investigation’s Combined DNA Index System database.
 

Commonwealth said that it has also been awarded about $300,000 from the US government for the initial examination of the proteomes of certain pathogens. The company expects to be allocated an additional $550,000 in fiscal year 2007 budget appropriations.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.